Angelini Pharma, a subsidiary of privately held Angelini Industries, and JCR Pharmaceuticals Co., Ltd. announced an exclusive global development and commercialization agreement for the development of novel biologic therapies utilising J-Brain...
Bayer and Bicycle Therapeutics plc, a biotechnology company pioneering a new and distinct class of therapeutics through the use of proprietary bicyclic peptides technology (Bicycle), announced a strategic collaboration agreement to discover,...
Pharmexcil, India's leading pharmaceutical export promotion organisation, has struck an agreement with the South Korean Pharmaceutical and Bio-Pharma Manufacturers Association to enhance market access and greater cooperation in the field...
Automation and streamlining of the research process are accelerating drug discovery.
Medikabazaar, a leading tech-driven healthcare supply chain Firm has joined hands with Andhra Pradesh Med Tech Zone (AMTZ) to set up an 8,000 sq. ft fulfillment centre within their premises. The centre will cater exclusively to the manufacturing...
Evonik has partnered with specialty chemicals distributor Safic-Alcan to bring nutraceuticals to a broader customer base. The collaboration began on May 1, 2023, and allows Evonik nutraceutical products such as AvailOm, IN VIVO BIOTICS, and...
Delix Therapeutics, a neuroscience company developing novel neuroplasticity-promoting therapeutics for psychiatric and neurological conditions, announced regulatory approval and the start of recruitment for its lead candidate, DLX-001,...
The Board of Directors of Sanofi India Limited today approved the Scheme of Arrangement between SIL and its wholly owned subsidiary Sanofi Consumer Healthcare India Limited (currently in the process of incorporation) ("SCHIL") to demerge SIL's ...
Takeda Biopharmaceuticals, formerly known as Baxalta Bioscience India, has launched its 'Sunrise Patient Services Programme (PSP)' in India for patients with hereditary angioedema (HAE). HAE is a potentially fatal rare genetic disease that affects...
On Tuesday, Mankind Pharma shares debuted on the stock exchange at a 20% premium. The shares closed the day with a 32% rise over the upper end of the IPO price band of Rs 1,080. The stock debuted on the BSE at Rs 1,300 and closed the day...
, CDSCO.jpg)
